Convulsive status epilepticus in children: etiology, treatment protocol and outcome

Eylem Ulas Saz1, Bulent Karapinar, Mustafa Ozcetin

  • 1Pediatric Emergency Department, Ege University School of Medicine, 35100 Bornova, Izmir, Turkey.

Seizure
|January 4, 2011
PubMed

Insights

This study evaluated a pediatric protocol for convulsive status epilepticus (SE) using diazepam and midazolam. The combined benzodiazepine approach proved safe and effective for treating pediatric SE, including refractory cases.

Area of Science:

  • Pediatric Neurology
  • Emergency Medicine
  • Clinical Pharmacology

Background:

  • Convulsive status epilepticus (SE) in children requires prompt and effective treatment.
  • Existing treatment protocols vary, necessitating evaluation of standardized approaches.
  • Understanding the etiology and outcomes of pediatric SE is crucial for improving patient care.

Purpose of the Study:

  • To determine the etiology, treatment protocol, and outcomes of convulsive SE in children.
  • To assess the efficacy and safety of an institutional treatment protocol (EPSEP) using benzodiazepines.
  • To categorize pediatric SE based on seizure duration and evaluate treatment responses.

Main Methods:

  • Retrospective case study analyzing pediatric SE episodes.
  • Implementation of the Ege Pediatric Status Epilepticus Protocol (EPSEP) with defined SE categories (initial, established, refractory).
  • Administration of diazepam and midazolam according to the protocol, including bolus and infusion strategies.

Main Results:

  • Meningitis or encephalitis was the etiology in 40% of cases; febrile SE occurred in 26%.
  • Initial SE (20-30 min) had limited success with rectal diazepam alone (7.5%).
  • Midazolam infusion achieved complete cessation of convulsive SE in 95% of 22 treated episodes (including refractory and established SE).

Conclusions:

  • The combined use of diazepam and midazolam is a safe and effective treatment strategy for pediatric convulsive SE.
  • The EPSEP protocol provides a structured approach to managing pediatric SE based on seizure duration.
  • Midazolam infusion is highly effective for established and refractory pediatric SE.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...